Azetidine → HCID 67363414, compound

HRID 1771385Notes

Reaction equation

[C:1]1([C:7]2[N:8]=[C:9]([NH2:21])[N:10]=[N:11][C:12]=2[C:13]2[CH:18]=[C:17]([CH3:19])[N:16]=[C:15](Cl)[CH:14]=2)[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1.[NH:22]1[CH2:25][CH2:24][CH2:23]1>>[N:22]1([C:15]2[CH:14]=[C:13]([C:12]3[N:11]=[N:10][C:9]([NH2:21])=[N:8][C:7]=3[C:1]3[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=3)[CH:18]=[C:17]([CH3:19])[N:16]=2)[CH2:25][CH2:24][CH2:23]1

Participants

Reactant 2

HCID 10422Azetidine

HCID 53353516HCID 53353516, compound

Product 1

HCID 67363414HCID 67363414, compound

Procedure

6-[2-(Azetidin-1-yl)-6-methylpyridin-4-yl]-5-phenyl-1,2,4-triazin-3-amine was prepared from 5-phenyl-6-(2-chloro-6-methyl-pyridin-4-yl)-1,2,4-triazin-3-amine (100 mg, 0.34 mmol) and azetidine (96 mg, 0.11 ml, 1.69 mmol) according to the general procedure for Preparation 4a.

Sources & evidence

ORD record: ord-1637fa2c6d12460798e537c77288c058
Source dataset: uspto-grants-2016_02
DOI: 10.6084/m9.figshare.5104873.v1
Patent number: US09249130B2

Reaction notes

Loading…